Sun Pharmaceutical Industries LtdSUNPHARMA:NSI

2.15 / 0.29%
13.14 %
Close in INRToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Jun 24 2016 11:29 BST.


On Friday, Sun Pharmaceutical Industries Ltd (SUNPHARMA:NSI) closed at 754.75, 7.21% above its 52-week low of 704.00, set on Nov 24, 2015.

52-week range
Nov 24 2015
Aug 20 2015
Day high765.00
Day low734.00
Previous close752.60
Average volume3.52m
Shares outstanding2.41bn
Free float1.10bn
P/E (TTM)38.47
Market cap1.82tn INR
EPS (TTM)19.62 INR
Annual div (IAD)3.00 INR
Annual div yield (IAD)0.40%
Div ex-dateOct 21 2015
Div pay-dateNov 30 2015
Data delayed at least 15 minutes, as of Jun 24 2016 11:29 BST.

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Sun Pharmaceutical Industries Ltd+1.86 %-3.61 %-4.51 %-13.14 %+207.90 %
NIFTY 50-1.00 %+1.94 %+2.89 %-3.68 %+47.84 %
IN/HEALTH CARE+1.05 %-1.58 %-9.87 %-13.49 %+54.45 %
IN/PHARMACEUTICALS+1.16 %-1.81 %-10.03 %-15.55 %+55.23 %
Data delayed at least 15 minutes, as of Jun 24 2016 11:29 BST.
© Thomson Reuters Click for restrictions.

All markets data located on is subject to the FT Terms & Conditions.

All content on is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.